{
  "node_id": "eu-ai-act-conformity-assessment-procedure",
  "title": "EU AI Act - Conformity Assessment Procedures for High-Risk AI Systems (Articles 43-49)",
  "domain": "AI Governance & Law",
  "version": "1.0.0",
  "last_updated": "2026-04-28",
  "bluf": "EU AI Act (Regulation 2024/1689) Articles 43-49 establish the conformity assessment framework that high-risk AI system providers must complete before placing their systems on the EU market; two conformity assessment tracks apply: (1) Article 43(1) mandatory third-party notified body assessment - applies to high-risk AI systems listed in Annex III Point 1 (biometric identification and categorisation systems) and to high-risk AI systems governed by Union harmonisation legislation in Annex I (medical devices, machinery, civil aviation, vehicles, personal protective equipment, in vitro diagnostic devices, rail interoperability, maritime equipment, lifts) where the relevant sectoral legislation already requires third-party assessment; notified bodies are independent conformity assessment bodies accredited by national accreditation bodies and notified to the European Commission; (2) Article 43(2) internal control self-assessment - applies to all other Annex III high-risk AI systems not covered by Article 43(1); under internal control, the provider verifies the AI system's compliance with Articles 8-15 requirements and draws up the technical documentation without third-party review; Article 47 provides for the EU declaration of conformity - providers must draw up a signed written declaration stating the high-risk AI system complies with the EU AI Act requirements; Article 48 establishes CE marking obligations - CE marking must be affixed to high-risk AI systems (or their accompanying documentation) before market placement, visibly, legibly, and indelibly; Article 49 requires registration of high-risk AI systems in the EU database for high-risk AI systems before placing on the market; conformity assessment must be completed before first market placement; providers must initiate a new or updated conformity assessment where the AI system undergoes substantial modification after market placement; the conformity assessment framework applies to providers established outside the EU who place high-risk AI on the EU market, who must appoint an authorised representative under Article 22.",
  "paywall": {
    "status": "LOCKED",
    "unlock_cost_usd": "0.01",
    "skyfire_id": "41779894-ece2-4163-9761-b3b1b76e19b0",
    "l402_paywall_url": "https://bidda.com/api/v1/vault/nodes/eu-ai-act-conformity-assessment-procedure.json"
  },
  "crosswalks": {
    "_available_keys": [
      "gdpr",
      "iso_27001",
      "nist_csf"
    ],
    "_note": "Full crosswalk values included in vault response"
  },
  "dependencies": [
    "eu-ai-act-2024",
    "eu-ai-act-article-3-definitions",
    "eu-ai-act-article-113-entry-into-force-application",
    "eu-ai-act-provider-obligations-high-risk",
    "eu-ai-act-technical-documentation-requirements",
    "eu-ai-act-high-risk-biometric-systems",
    "eu-ai-act-sme-startup-provisions"
  ],
  "primary_citations_count": 5
}